Terms: = Leukemia AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID AND Clinical Outcome
5 results:
1. Alterations in regulatory T cells and immune checkpoint molecules in pancreatic cancer patients receiving FOLFIRINOX or gemcitabine plus nab-paclitaxel.
Sams L; Kruger S; Heinemann V; Bararia D; Haebe S; Alig S; Haas M; Zhang D; Westphalen CB; Ormanns S; Metzger P; Werner J; Weigert O; von Bergwelt-Baildon M; Rataj F; Kobold S; Boeck S
Clin Transl Oncol; 2021 Nov; 23(11):2394-2401. PubMed ID: 33876417
[TBL] [Abstract] [Full Text] [Related]
2. CD52/GPI- T-Cells Are Enriched for Alloreactive Specificity and Predict Acute Graft-Versus-Host-Disease After Stem Cell Transplantation.
Kinsella FA; Inman CF; Croft W; Zuo J; Pearce H; Barbieri S; Craddock C; Malladi R; Moss P
Transplant Cell Ther; 2021 Jun; 27(6):475.e1-475.e9. PubMed ID: 33863699
[TBL] [Abstract] [Full Text] [Related]
3. Role of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy.
Sander FE; Nilsson M; Rydström A; Aurelius J; Riise RE; Movitz C; Bernson E; Kiffin R; Ståhlberg A; Brune M; Foà R; Hellstrand K; Thorén FB; Martner A
Cancer Immunol Immunother; 2017 Nov; 66(11):1473-1484. PubMed ID: 28721449
[TBL] [Abstract] [Full Text] [Related]
4. Elevated frequencies of CD4⁺ CD25⁺ CD127lo regulatory T cells is associated to poor prognosis in patients with acute myeloid leukemia.
Shenghui Z; Yixiang H; Jianbo W; Kang Y; Laixi B; Yan Z; Xi X
Int J Cancer; 2011 Sep; 129(6):1373-81. PubMed ID: 21105040
[TBL] [Abstract] [Full Text] [Related]
5. CD4 (+)CD25 (+)foxp3 (+) regulatory T cells and hematologic malignancies.
Kelley TW; Parker CJ
Front Biosci (Schol Ed); 2010 Jun; 2(3):980-92. PubMed ID: 20515837
[TBL] [Abstract] [Full Text] [Related]
